Aspen Allergy Conference 2019

Aspen, CO US
July 28, 2019 to August 1, 2019

The Aspen Allergy Conference is a four consecutive half-day and thematic meeting to foster didactic lectures in an interactive format with the attendees. There is a maximum capacity of approximately 175 attendees in the lecture hall. This allows a very intimate setting for learning. The Aspen Allergy Conference is structured to host three State of the Art speakers from around the United States and abroad each day.


Registration Information

Registration fee information follows.

Registrant TypeFee
Colorado Allergy Society MemberFREE
Physician$400
Physician Assistant$400

Online registration will close at 4:00 p.m. on Friday, July 19. On-site registration will open on the afternoon of Sunday, July 28 at Hotel Jerome.

Please click the Venue tab for accommodation information.


Credit Claiming

Credit claiming should open no later than 12:00 p.m. on Monday, August 5, 2019 and will remain open through 11:59 pm on Tuesday, June 30, 2020. Credit claiming requests on or after July 1, 2020 will be subject to an administrative fee.


Commercial Support

Aspen Allergy Conference is supported by educational grants from Stallergenes Greer, Lincoln Diagnostics, and the Colorado Allergy & Asthma Society.


 

Target Audience

  • A/I Physicians
  • Fellows-in-Training
  • Nurse Practitioners
  • Physician Assistants

 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe best use of prescribing inhaled steroids in severe asthma
  • Effectively treat pediatric asthma
  • Evaluate and treat EGPA
  • Understand the role of barriers and Type 2 inflammation in atopic dermatitis
  • Diagnose and treat atopic dermatitis in the clinical setting
  • Recognize treatment options for serious inflammatory disorders
  • Describe the best treatment of allergic disease
  • Understand new mechanisms of and treatment modalities for hereditary angioedema
  • Describe the phenotypes in the upper airway
  • Describe the best new treatments for nasal polyposis
  • Determine treatment algorithms for aspirin-exasperated respiratory disease

 
Summary
Available credit: 
  • 16.00 Attendance
    Attendance credit.
  • 16.00 CME
    CME credit.
Course opens: 
05/30/2019
Course expires: 
06/30/2020
Event starts: 
07/28/2019 - 12:00pm CDT
Event ends: 
08/01/2019 - 12:30pm CDT
Cost:
$400.00
Rating: 
0
Hotel Jerome
330 East Main Street
Aspen, CO 81611
United States
Planning Committee

Fred (Dan) Atkins, MD FAAAAI
Children's Hospital of Colorado, Aurora, CO
Relevant relationships: None

Donna Bratton, MD
National Jewish Health, Denver, CO
Relevant relationships: None

Richard Weber, MD FAAAAI
Retired Physician
Relevant relationships: None

Stephen Dreskin, MD PhD FAAAAI
University of Colorado, Aurora, CO
Relevant relationships: None

Flavia Hoyte, MD
National Jewish Health, Denver, CO
Relevant relationships: None

John James, MD FAAAAI
Colorado Allergy and Asthma Centers, PC, Fort Collins, CO
Relevant relationships: None

Charles Kirkpatrick, MD FAAAAI
University of Colorado Health Sciences Center, Denver, CO
Relevant relationships: None

Harold Nelson, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: None

David Pearlman, MD FAAAAI
Colorado Allergy and Asthma Centers, Denver, CO
Relevant relationships: None

Lanny Rosenwasser, MD FAAAAI
Overland Park, KS
Relevant relationships: None

Alan Schocket, MD MSHA
University of Colorado, Denver, CO
Relevant relationships: None

Gary Siegel, MD
Denver Allergy and Asthma, Lakewood, CO
Relevant relationships: None

William Silvers, MD FAAAAI
University of Colorado, Denver, CO
Relevant relationships: None

Faculty

Eugene Bleecker, MD FAAAAI
University of Arizona, Tucson, AZ
Relevant relationships: AstraZeneca, GSK, Novartis, Regeneron, Sanofi Genzyme (consultant)

Mark Boguniewicz, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Regeneron, Sanofi (advisory board); Regeneron (speaker: dupliumab), Regeneron (research grant)

Larry Borish, MD FAAAAI
University of Virginia, Charlottesville, VA
Relevant relationships: Allakos, AstraZeneca, Regeneron-Sanofi, Novartis (consultant); AstraZeneca, GSK (research grant)

Joshua Boyce, MD FAAAAI
Harvard Medical School and Brigham and Women's Hospital, Boston, MA
Relevant relationships: None

Talal Chatila, MD MSc
Harvard Medical School and Boston Children's Hospital, Boston, MA
Relevant relationships: None

Lawrence Eichenfield, MD
University of California San Diego, San Diego, CA
Relevant relationships: Leo Pharma, Lilly Pharma, Demira, Sanofi Genzyme/Regeneron (consultant); Pfizer (research grant)

Bob Geng, MD
University of California San Diego, San Diego, CA
Relevant relationships: Optinose, Regeneron, Horizon, CSL Behring (speaker); Pharming, Shire (advisory board); Stallergenes, Octoapharma, GSK, Genentech (research grant); Novartis (consultant) 

Shikha Gupta, MD
National Jewish Health, Denver, CO
Relevant relationships: None

Carolina Gutierrez, MD
University of Colorado, Denver, CO
Relevant relationships: None

Hal Hoffman, MD FAAAAI
University of California, San Diego
Relevant relationships: Novartis (consultant: IL-1 therapy)

Donald Leung, MD PhD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Abbvie, Aimmune, Incyte, Novartis, Regeneron, Sanofi, Pfizer (advisory board)

Wanda Phipatanakul, MD MS FAAAAI
Boston Children's Hospital, Boston, MA
Relevant relationships: Genentech, Novartis, Teva, Regeneron/Sanofi, GSK (advisory board)

Ronald Simon, MD FAAAAI
Scripps Clinic, San Diego, CA
Relevant relationships: None

Michael Wechsler, MD
National Jewish Health, Denver, CO
Relevant relationships: Genentech, Pulmatrix, Gala Therapeutics, Mylan, Boston Scientific, Boehringer Ingelheim, Novartis, Regeneron, Teva, Genzyme, AstraZeneca, Sanofi, GKS (consultant); Sentien (advisory board)

Bruce Zuraw, MD
University of California San Diego and San Diego VA Medical Center, San Diego, CA
Relevant relationships: BioCryst, Sanofi-Aventis, CSL Behring, Shire, Novartis (consultant)

Content Reviewer

Thomas Miller, MD FAAAAI
Allergy Associates of Western Michigan, Grandville, MI
Relevant relationships: AstraZeneca: asthma


AAAAI Disclosure Policy

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

  • Employment: Name of employer and job title.
  • Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the Aspen Allergy Conference. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on June 30, 2020. Requests to claim credit on or after July 1, 2020 will be subject to an administrative fee.


Medium and Method of Physician Participation for a Live Activity

Follow these steps to complete the activity:

  1. Register for the activity.
  2. Review the CME and Disclosure information.
  3. View any pre-meeting information and/or complete the pre-test, if available.
  4. Attend the meeting. Be sure to sign in so your attendance can be recorded.
  5. Return to the online meeting site after the meeting and complete the post-test, if required. You must achieve a score of 70% or higher on post-tests to claim credit.
  6. Complete the activity evaluation.
  7. Claim your credits. Enter only the number of credits earned based on your participation in the activity.
  8. Print or save your certificate.

AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.


Questions

Activity-related questions should be directed to Jill Hibbeln at jillhibbeln@gmail.com.

Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 16.00 Attendance
    Attendance credit.
  • 16.00 CME
    CME credit.

Price

Cost:
$400.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.